Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset
Notified -
Globe Newswire22-09-2025, 22:02
Fortinet Survey Finds 78% of Organizations Felt Prepared for Ransomware Attacks, Yet Half Still Fell Victim 24-04-2023, 20:00
